{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:37:49Z","timestamp":1791995869591,"version":"4.4.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T00:00:00Z","timestamp":1292976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Kawasaki disease (KD) is an acute vasculitis affecting mainly infants and children. Human B cells express Toll-like receptor (TLR)-9, whose natural ligands are unmethylated cytosine\u2013guanine dinucleotide (CpG) motifs characteristic of bacterial DNA. The aim of this study was to clarify the pathogenesis of KD analysing the activation status of peripheral blood mononuclear cells (PBMC), focusing on B lymphocyte activation and functions. Ten patients and 10 age-matched healthy donors were recruited from the Bambino Ges\u00f9 Hospital of Rome, Italy and enrolled into this study. We determined phenotype profile and immunoglobulin (Ig) production of PBMC from KD patients and age-matched controls. We found that the frequency of CD19+ B lymphocytes and CD19+\/CD86+ activated B lymphocytes from KD patients during the acute phase before therapy was increased significantly. Moreover, B lymphocytes of acute-phase KD patients were more prone to CpG oligodeoxynucleotide (ODN) activation compared with the age-matched controls, as assessed by a significant increase of the number of IgA-secreting cells (SC). In the same patients we found a marked increase of IgM, IgG, interleukin (IL)-6 and tumour necrosis factor (TNF)-\u03b1 production compared with the control group. In addition, in two convalescent KD patients, conventional treatment with intravenous immunoglobulin (IVIG) restored the normal frequency of CD19+ B cells, the number of IgA-, IgM- and IgG-SC and the production of IL-6 and TNF-\u03b1. Our findings indicate that the percentages of peripheral B lymphocytes of acute-phase KD patients are increased and are prone to bacterial activation in terms of increased numbers of IgA-SC and increased production of IL-6 and TNF-\u03b1 inflammatory cytokines. Thus, our data support the hypothesis of an infectious triggering in KD.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04297.x","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T19:18:45Z","timestamp":1293045525000},"page":"346-353","source":"Crossref","is-referenced-by-count":28,"title":["Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease"],"prefix":"10.1093","volume":"163","author":[{"given":"L","family":"Giordani","sequence":"first","affiliation":[{"name":"Department of Therapeutic Research and Medicine Evaluation, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Quaranta","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Research and Medicine Evaluation, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Marchesi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Bambino Ges\u00f9 Hospital, Rome, Italy, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Straface","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Research and Medicine Evaluation, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Pietraforte","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Neurosciences, Istituto Superiore di Sanit\u00e0, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Villani","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Bambino Ges\u00f9 Hospital, Rome, Italy, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Malorni","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Research and Medicine Evaluation, Rome, Italy"},{"name":"Istituto San Raffaele Sulmona, L'Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Del Principe","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Research and Medicine Evaluation, Rome, Italy"},{"name":"Istituto San Raffaele Sulmona, L'Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Viora","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Research and Medicine Evaluation, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"2021122708482522100_b1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.54.3.271","article-title":"A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan","volume":"54","author":"Kawasaki","year":"1974","journal-title":"Pediatrics"},{"key":"2021122708482522100_b2","first-page":"218","article-title":"Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome)","volume":"1","author":"Landing","year":"1987","journal-title":"Am J Cardiovasc Pathol"},{"key":"2021122708482522100_b3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOP.0b013e328012720f","article-title":"New developments in the search for the etiologic agent of Kawasaki disease","volume":"19","author":"Rowley","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"2021122708482522100_b4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"2021122708482522100_b5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrmicro1853","article-title":"Searching for the cause of Kawasaki disease \u2013 cytoplasmic inclusion bodies provide new insight","volume":"6","author":"Rowley","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"2021122708482522100_b6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QCO.0b013e3280964d8c","article-title":"The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease","volume":"20","author":"Matsubara","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"2021122708482522100_b7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.bor.0000174184.15901.ee","article-title":"Pathogenesis and treatment of Kawasaki disease","volume":"17","author":"Yeung","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"2021122708482522100_b8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2249.2009.04073.x","article-title":"Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease","volume":"160","author":"Ikeda","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021122708482522100_b9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2249.2005.02821.x","article-title":"Immunological profile of peripheral blood lymphocytes and monocytes\/macrophages in Kawasaki disease","volume":"141","author":"Matsubara","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"2021122708482522100_b10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2249.2007.03567.x","article-title":"T cell activation profiles in Kawasaki syndrome","volume":"151","author":"Brogan","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2021122708482522100_b11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3349\/ymj.2009.50.4.493","article-title":"Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease","volume":"50","author":"Lee","year":"2009","journal-title":"Yonsei Med J"},{"key":"2021122708482522100_b12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2249.2002.02000.x","article-title":"The role of anti-endothelial cell antibodies in Kawasaki disease \u2013in vitro and in vivo studies","volume":"130","author":"Grunebaum","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2021122708482522100_b13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0022-3476(05)80343-9","article-title":"Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease","volume":"121","author":"Lin","year":"1992","journal-title":"J Pediatr"},{"key":"2021122708482522100_b14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-065X.2007.00572.x","article-title":"Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity","volume":"220","author":"Krieg","year":"2007","journal-title":"Immunol Rev"},{"key":"2021122708482522100_b15","first-page":"818","article-title":"Change of MyD88-independent signal transduction of Toll-like receptor 4 in immunological pathogenesis of Kawasaki disease","volume":"45","author":"Wang","year":"2007","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2021122708482522100_b16","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management in Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young. American Heart Association","volume":"114","author":"Newburger","year":"2004","journal-title":"Pediatrics"},{"key":"2021122708482522100_b17","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"2021122708482522100_b18","first-page":"241","volume-title":"ELISA and other solid phase immunoassays","author":"Sedgwick","year":"1988"},{"key":"2021122708482522100_b19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0022-1759(88)90055-5","article-title":"Enumeration of IFN-gamma-producing human lymphocytes by spot-ELISA. A method to detect lymphokine-producing lymphocytes at the single-cell level","volume":"111","author":"Versteegen","year":"1988","journal-title":"J Immunol Methods"},{"key":"2021122708482522100_b20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cellimm.2010.07.003","article-title":"Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease","volume":"265","author":"Ehara","year":"2010","journal-title":"Cell Immunol"},{"key":"2021122708482522100_b21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/infdis\/163.2.416","article-title":"Comparison of Kawasaki disease and infectious mononucleosis in terms of natural killer cell and CD8+ T cell subsets","volume":"163","author":"Furukawa","year":"1991","journal-title":"Infect Dis"},{"key":"2021122708482522100_b22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1203\/00006450-200110000-00019","article-title":"Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease","volume":"50","author":"Shingadia","year":"2001","journal-title":"Pediatr Res"},{"key":"2021122708482522100_b23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/clin.1997.4376","article-title":"Imunoregulatory changes in Kawasaki disease","volume":"84","author":"Jason","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"2021122708482522100_b24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/adc.67.6.706","article-title":"Mononuclear cell subsets and coronary artery lesions in Kawasaki disease","volume":"67","author":"Furukawa","year":"1992","journal-title":"Arch Dis Child"},{"key":"2021122708482522100_b25","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.4049\/jimmunol.130.5.2002","article-title":"Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome","volume":"130","author":"Leung","year":"1983","journal-title":"J Immunol"},{"key":"2021122708482522100_b26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0090-1229(82)90075-7","article-title":"Immunoregulatory abnormalities in mucocutaneous lymph node syndrome","volume":"23","author":"Leung","year":"1982","journal-title":"Clin Immunol Immunopathol"},{"key":"2021122708482522100_b27","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of Toll-like receptor 1\u201310 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J Immunol"},{"key":"2021122708482522100_b28","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/ni.1669","article-title":"Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9","volume":"9","author":"Park","year":"2008","journal-title":"Nat Immunol"},{"key":"2021122708482522100_b29","first-page":"49","article-title":"Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease","volume":"46","author":"Wang","year":"2008","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2021122708482522100_b30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1442-200X.2002.01506.x","article-title":"Increased production of serum IgA-class antibody to lipid A in Kawasaki disease","volume":"44","author":"Takeshita","year":"2002","journal-title":"Pediatr Int"},{"key":"2021122708482522100_b31","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.4049\/jimmunol.159.12.5946","article-title":"IgA plasma cells in vascular tissue of patients with Kawasaki syndrome","volume":"159","author":"Rowley","year":"1997","journal-title":"J Immunol"},{"key":"2021122708482522100_b32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1086\/315832","article-title":"IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease","volume":"182","author":"Rowley","year":"2000","journal-title":"J Infect Dis"},{"key":"2021122708482522100_b33","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.4049\/jimmunol.166.2.1334","article-title":"Oligoclonal IgA response in the vascular wall in acute Kawasaki disease","volume":"166","author":"Rowley","year":"2001","journal-title":"J Immunol"},{"key":"2021122708482522100_b34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/03009740410005034","article-title":"Circulating interleukin 17 is increased in the acute stage of Kawasaki disease","volume":"32","author":"Sohn","year":"2003","journal-title":"Scand J Rheumatol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04297.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/163\/3\/346\/41909432\/j.1365-2249.2010.04297.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/163\/3\/346\/41909432\/j.1365-2249.2010.04297.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T15:54:14Z","timestamp":1685894054000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/163\/3\/346\/6428951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,12,22]]},"published-print":{"date-parts":[[2011,2,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04297.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,3]]},"published":{"date-parts":[[2010,12,22]]}}}